Literature DB >> 12556431

Antibiotic consumption and resistance selection in Streptococcus pneumoniae.

F Baquero1, G Baquero-Artigao, R Cantón, C García-Rey.   

Abstract

Selection of antibiotic-resistant Streptococcus pneumoniae is an inescapable consequence of antibiotic use. The correlation between antibiotic consumption and selection of resistant organisms can be shown at every ecological level: patient, community, region or country. In the case of multiple resistance, the intensity of antibiotic selection is increased. However, different antibiotics may exert different selective powers. Because of this, co-selection of macrolide and beta-lactam resistance is an asymmetrical phenomenon: macrolides select more efficiently strains resistant to both macrolides and beta-lactams than aminopenicillins. The difference in rates of antibiotic resistance is also influenced by the local spread of susceptible or resistant clones; it is suggested that under mild antibiotic selection, the susceptible organisms that are more fit for host-to-host transmission could be favoured. Subsequent acquisition of resistance in these clones may rapidly increase the prevalence of resistance, and that may lead to an increase in the use of antibiotics. The reasons for antibiotic resistance are mainly the reasons explaining antibiotic consumption. A number of possible sociobiological determinants of antibiotic consumption can be identified: genetic factors in the human populations (for instance, involving different symptomatic types of infection), cultural factors and attitudes of patients towards antibiotics, sociological factors or public health factors, including incidence of other infectious diseases in the human population. Only 'excess' in the use of antibiotics should be controlled; for such a purpose, the concept, 'appropriate demand for antibiotics' (ADA) is proposed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12556431     DOI: 10.1093/jac/dkf504

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  17 in total

1.  Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital.

Authors:  Arno Muller; Dominique L Monnet; Daniel Talon; Thierry Hénon; Xavier Bertrand
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

2.  Trends in resistance to penicillin and erythromycin of invasive pneumococci in Portugal.

Authors:  R Dias; M Caniça
Journal:  Epidemiol Infect       Date:  2007-08-16       Impact factor: 2.451

3.  Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.

Authors:  Robert E Fintelmann; Eliza N Hoskins; Thomas M Lietman; Jeremy D Keenan; Bruce D Gaynor; Vicky Cevallos; Nisha R Acharya
Journal:  Arch Ophthalmol       Date:  2011-04

4.  In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.

Authors:  Takafumi Sato; Kazuhiro Tateda; Soichiro Kimura; Morihiro Iwata; Yoshikazu Ishii; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

5.  Amoxicillin-resistant Streptococcus pneumoniae can be resensitized by targeting the mevalonate pathway as indicated by sCRilecs-seq.

Authors:  Liselot Dewachter; Julien Dénéréaz; Xue Liu; Vincent de Bakker; Charlotte Costa; Mara Baldry; Jean-Claude Sirard; Jan-Willem Veening
Journal:  Elife       Date:  2022-06-24       Impact factor: 8.713

6.  Increasing penicillin and trimethoprim-sulfamethoxazole resistance in nasopharyngeal Streptococcus pneumoniae isolates from Guatemalan children, 2001--2006.

Authors:  Erica L Dueger; Edwin J Asturias; Jorge Matheu; Remei Gordillo; Olga Torres; Neal Halsey
Journal:  Int J Infect Dis       Date:  2007-11-26       Impact factor: 3.623

7.  Connection between trimethoprim-sulfamethoxazole use and resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.

Authors:  Pauliina Kärpänoja; Solja T Nyberg; Miika Bergman; Tinna Voipio; Pirkko Paakkari; Pentti Huovinen; Hannu Sarkkinen
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

8.  Nasopharyngeal Carriage, Antibiotic Resistance and Serotype Distribution of Streptococcus Pneumoniae among Healthy Adolescents in Zahedan.

Authors:  M Bokaeian; H A Khazaei; M Javadimehr
Journal:  Iran Red Crescent Med J       Date:  2011-05-01       Impact factor: 0.611

9.  Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece.

Authors:  Ioannis Katsarolis; Garyphallia Poulakou; Antonios Analitis; Irini Matthaiopoulou; Emmanuel Roilides; Charalampos Antachopoulos; Dimitrios A Kafetzis; Georgios L Daikos; Regina Vorou; Christina Koubaniou; Ioannis Pneumatikos; Georgios Samonis; Vasiliki Syriopoulou; Helen Giamarellou; Kyriaki Kanellakopoulou
Journal:  BMC Infect Dis       Date:  2009-07-29       Impact factor: 3.090

Review 10.  Incorporation of Antibiotics into Solid Lipid Nanoparticles: A Promising Approach to Reduce Antibiotic Resistance Emergence.

Authors:  Lide Arana; Lucia Gallego; Itziar Alkorta
Journal:  Nanomaterials (Basel)       Date:  2021-05-10       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.